Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN336091 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Epilepsy, Progressive Myoclonus Type 2A, Lafora Disease (Laforin) (EPM2A) (AA 243-331) antibody
- Antibody type
- Monoclonal
- Description
- Protein-G affinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 243-331
- Isotype
- IgG
- Antibody clone number
- k2A3
- Vial size
- 50 μL
- Storage
- Store the antibody undiluted at 2-8°C for up to two weeks or (in aliquots) at -20°C forlonger. Avoid repeated freezing and thawing.Shelf life: one year from despatch.
Submitted references Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.
Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
Tagliabracci VS, Turnbull J, Wang W, Girard JM, Zhao X, Skurat AV, Delgado-Escueta AV, Minassian BA, Depaoli-Roach AA, Roach PJ
Proceedings of the National Academy of Sciences of the United States of America 2007 Dec 4;104(49):19262-6
Proceedings of the National Academy of Sciences of the United States of America 2007 Dec 4;104(49):19262-6
Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
Wang W, Parker GE, Skurat AV, Raben N, DePaoli-Roach AA, Roach PJ
Biochemical and biophysical research communications 2006 Nov 24;350(3):588-92
Biochemical and biophysical research communications 2006 Nov 24;350(3):588-92
Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
Ganesh S, Delgado-Escueta AV, Suzuki T, Francheschetti S, Riggio C, Avanzini G, Rabinowicz A, Bohlega S, Bailey J, Alonso ME, Rasmussen A, Thomson AE, Ochoa A, Prado AJ, Medina MT, Yamakawa K
Human molecular genetics 2002 May 15;11(11):1263-71
Human molecular genetics 2002 May 15;11(11):1263-71
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB